Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith Y Smith

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Diabetes Care|July 20, 2023
A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of TreatmentsAlmut G Winterstein, Vera Ehrenstein, Jeffrey S Brown, et al.
Pharmacoepidemiology and Drug Safety|September 23, 2008
Detecting signals of opioid analgesic abuse: application of a spatial mixed effect poisson regression model using data from a network of poison control centersMeredith Y Smith, William Irish, Jianmin Wang, et al.
Journal of Pain and Symptom Management|July 11, 2006
Patient-physician communication in the context of persistent pain: validation of a modified version of the patients' Perceived Involvement in Care ScaleMeredith Y Smith, Gary Winkel, Jennifer Egert, et al.
Managed Care (Langhorne, Pa.)|October 3, 2007
Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary careMeredith Y Smith, Jerry Cromwell, Judith DePue, et al.
Drug and Alcohol Dependence|May 17, 2008
Reducing opioid. analgesic abuse: models for successful collaboration among government, industry and other key stakeholdersMeredith Y Smith, Herbert D Kleber, Nathanial Katz, et al.
Drug and Alcohol Dependence|April 4, 2006
Risk identification, risk assessment, and risk management of abusable drug formulationsCurtis Wright, E Douglas Kramer, Mary-Ann Zalman, et al.
Therapeutic Innovation & Regulatory Science|October 28, 2020
Quantitative Benefit-Risk Assessment: State of the Practice Within IndustryMeredith Y Smith, Janine van Til, Rachael L DiSantostefano, et al.
Drug Safety|February 10, 2021
Risk Management for the 21st Century: Current Status and Future NeedsRania Mouchantaf, Doris Auth, Yola Moride, et al.
Journal of Public Health Policy|March 24, 2022
The case for using mixed methods for designing, implementing, and disseminating evidence-based interventions for public health practiceMeredith Y Smith, Sandy-Asari Hogan, Susan M Jack, et al.
Drug Safety|March 13, 2024
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE)Meredith Y Smith, Elaine H Morrato, Nallely Mora, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Diabetes Care|July 20, 2023
A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of TreatmentsAlmut G Winterstein, Vera Ehrenstein, Jeffrey S Brown, et al.
Pharmacoepidemiology and Drug Safety|September 23, 2008
Detecting signals of opioid analgesic abuse: application of a spatial mixed effect poisson regression model using data from a network of poison control centersMeredith Y Smith, William Irish, Jianmin Wang, et al.
Journal of Pain and Symptom Management|July 11, 2006
Patient-physician communication in the context of persistent pain: validation of a modified version of the patients' Perceived Involvement in Care ScaleMeredith Y Smith, Gary Winkel, Jennifer Egert, et al.
Managed Care (Langhorne, Pa.)|October 3, 2007
Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary careMeredith Y Smith, Jerry Cromwell, Judith DePue, et al.
Drug and Alcohol Dependence|May 17, 2008
Reducing opioid. analgesic abuse: models for successful collaboration among government, industry and other key stakeholdersMeredith Y Smith, Herbert D Kleber, Nathanial Katz, et al.
Drug and Alcohol Dependence|April 4, 2006
Risk identification, risk assessment, and risk management of abusable drug formulationsCurtis Wright, E Douglas Kramer, Mary-Ann Zalman, et al.
Therapeutic Innovation & Regulatory Science|October 28, 2020
Quantitative Benefit-Risk Assessment: State of the Practice Within IndustryMeredith Y Smith, Janine van Til, Rachael L DiSantostefano, et al.
Drug Safety|February 10, 2021
Risk Management for the 21st Century: Current Status and Future NeedsRania Mouchantaf, Doris Auth, Yola Moride, et al.
Journal of Public Health Policy|March 24, 2022
The case for using mixed methods for designing, implementing, and disseminating evidence-based interventions for public health practiceMeredith Y Smith, Sandy-Asari Hogan, Susan M Jack, et al.
Drug Safety|March 13, 2024
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE)Meredith Y Smith, Elaine H Morrato, Nallely Mora, et al.
Pageof 5